May 30, 2018

Ambien Hits Back at Roseanne: “Racism Is Not a Known Side Effect”

The just-fired TV host had blamed her sleeping pills for a bigoted tweet.

Kristin Callahan/ZUMA

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.

The manufacturer of Ambien is pushing back against Roseanne Barr’s attempt to blame the drug for a racist tweet she published and deleted Tuesday. 

“People of all races, religions and nationalities work at Sanofi every day to improve the lives of people around the world,” Sanofi US, the company behind the commonly prescribed sleeping pill, said in a Wednesday statement. “While all pharmaceutical treatments have side effects, racism is not a known side effect of any Sanofi medication.”

The company was responding to another since deleted tweet Barr sent on Wednesday, where the TV star claimed “ambien tweeting” prompted her to liken Valerie Jarrett, a former senior adviser to Barack Obama who is black, to an ape. Just hours after that tweet gained attention on social media, ABC said it was canceling Roseanne for what it denounced as an “abhorrent” and “repugnant” statement by Barr.

The 2018 reboot of the popular sitcom had been attracting high ratings—even while some jokes drew controversy and as Barr kept up her well-established record of promoting baseless, right-wing conspiracy theories.

Despite Barr’s announcement that she would soon be leaving Twitter, along with a public apology she sent to Jarrett, Barr continued to retweet right-wing conspiracy theories about the former Obama adviser well into Wednesday evening. Other Barr retweets suggested ABC was wrong to cancel Roseanne and that Barr thought the company had applied a double standard in choosing to dismiss her.

WE'LL BE BLUNT:

We need to start raising significantly more in donations from our online community of readers, especially from those who read Mother Jones regularly but have never decided to pitch in because you figured others always will. We also need long-time and new donors, everyone, to keep showing up for us.

In "It's Not a Crisis. This Is the New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, how brutal it is to sustain quality journalism right now, what makes Mother Jones different than most of the news out there, and why support from readers is the only thing that keeps us going. Despite the challenges, we're optimistic we can increase the share of online readers who decide to donate—starting with hitting an ambitious $300,000 goal in just three weeks to make sure we can finish our fiscal year break-even in the coming months.

Please learn more about how Mother Jones works and our 47-year history of doing nonprofit journalism that you don't find elsewhere—and help us do it with a donation if you can. We've already cut expenses and hitting our online goal is critical right now.

payment methods

WE'LL BE BLUNT

We need to start raising significantly more in donations from our online community of readers, especially from those who read Mother Jones regularly but have never decided to pitch in because you figured others always will. We also need long-time and new donors, everyone, to keep showing up for us.

In "It's Not a Crisis. This Is the New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, how brutal it is to sustain quality journalism right now, what makes Mother Jones different than most of the news out there, and why support from readers is the only thing that keeps us going. Despite the challenges, we're optimistic we can increase the share of online readers who decide to donate—starting with hitting an ambitious $300,000 goal in just three weeks to make sure we can finish our fiscal year break-even in the coming months.

Please learn more about how Mother Jones works and our 47-year history of doing nonprofit journalism that you don't elsewhere—and help us do it with a donation if you can. We've already cut expenses and hitting our online goal is critical right now.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate